The sense of stopping migraine prophylaxis

INTRODUCTION: Migraine prophylactic therapy has changed over recent years with the development and approval of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway. As new therapies emerged, leading headache societies have been providing guidelines on the initiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Hassany, Linda, Lyons, Hannah S., Boucherie, Deirdre M., Farham, Fatemeh, Lange, Kristin S., Marschollek, Karol, Onan, Dilara, Pensato, Umberto, Storch, Elisabeth, Torrente, Angelo, Waliszewska-Prosół, Marta, Reuter, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933401/
https://www.ncbi.nlm.nih.gov/pubmed/36792981
http://dx.doi.org/10.1186/s10194-023-01539-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933401/
https://www.ncbi.nlm.nih.gov/pubmed/36792981
http://dx.doi.org/10.1186/s10194-023-01539-8

Ejemplares similares